Skip to main content
OpenTrials

Clinical trial condition

Major Depressive Disorder

Explore clinical trials studying Major Depressive Disorder. Study availability and eligibility vary by location and protocol.

1,339 public trials 169 recruiting studies
Refine in advanced search Browse all conditions

Major Depressive Disorder trial results

Completed

Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive Disorder

NCT00798707

Conditions
Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder, +2 more
Locations
  • Pfizer Investigational Site Arcadia, California, United States
  • Pfizer Investigational Site Beverly Hills, California, United States
  • Pfizer Investigational Site Cerritos, California, United States
  • Pfizer Investigational Site Garden Grove, California, United States
View all 78 locations
View Trial Details
Completed

Study Evaluating Desvenlafaxine Succinate Sustained Release In Adults With Major Depressive Disorder

NCT00863798

Conditions
Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder, +2 more
Locations
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Encino, California, United States
  • Pfizer Investigational Site Newport Beach, California, United States
  • Pfizer Investigational Site Redlands, California, United States
View all 24 locations
View Trial Details
Completed

Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder

NCT01309542

Conditions
Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder, +2 more
Locations
  • Birmingham Research Group Inc. Birmingham, Alabama, United States
  • Pivotal Research Centers 13128 North 94th Drive, Suite 200 Mesa, Arizona, United States
  • Pivotal Research Peoria, Arizona, United States
  • Southwestern Research, Inc. Beverly Hills, California, United States
View all 117 locations
View Trial Details
Completed

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Child And Adolescent Outpatients With Major Depressive Disorder

NCT00619619

Conditions
Behavior, Behavioral Symptoms, Depression, +5 more
Locations
  • Pfizer Investigational Site Little Rock, Arkansas, United States
  • Pfizer Investigational Site North Miami, Florida, United States
  • Pfizer Investigational Site Terre Haute, Indiana, United States
  • Pfizer Investigational Site Wichita, Kansas, United States
View Trial Details
Completed

Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder

NCT00351910

Conditions
Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder, +2 more
Locations
  • Research Site Everton Park, Queensland, Australia
  • Research Site Southport, Queensland, Australia
  • Research Site Frankston, Victoria, Australia
  • Research Site Malvern, Victoria, Australia
View all 72 locations
View Trial Details
Completed

Randomized, Double-Blind, Placebo Controlled Study of Vilazodone's Efficacy, Safety, and Biomarkers of Response in Major Depressive Disorder (MDD)

NCT00683592

Conditions
Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder, +2 more
Locations
  • Pharmacology Research Institute Newport Beach, California, United States
  • Florida Clinical Research Center Bradenton, Florida, United States
  • Atlanta Institute of Medicine and Research Atlanta, Georgia, United States
  • Summit Research Network Portland, Oregon, United States
View Trial Details
Completed

A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Treatment of Depression in Elderly Patients

NCT00406848

Conditions
Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder, +2 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pasadena, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sherman Oaks, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamden, Connecticut, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Coral Springs, Florida, United States
View all 33 locations
View Trial Details

Related conditions